Four-helix bundle growth factors and their receptors: protein-protein interactions.

Many growth factors and cytokines promote receptor clustering on binding. At least three different protein-protein interaction sites are involved: cytokine-receptor I, cytokine-receptor II and receptor I-receptor II. Although structural data on these complexes are limited, recent structural and mutagenesis studies of the four-helix bundle class of cytokines are clarifying the nature of the complexes formed.

[1]  G. Ciliberto,et al.  Generation of interleukin‐6 receptor antagonists by molecular‐modeling guided mutagenesis of residues important for gp130 activation. , 1994, The EMBO journal.

[2]  W. Sebald,et al.  Neutralizing monoclonal antibodies define two different functional sites in human interleukin-4. , 1994, European journal of biochemistry.

[3]  D. Cosman,et al.  Utilization of the beta and gamma chains of the IL‐2 receptor by the novel cytokine IL‐15. , 1994, EMBO Journal.

[4]  R A Smith,et al.  Loop mobility in a four-helix-bundle protein: 15N NMR relaxation measurements on human interleukin-4. , 1992, Biochemistry.

[5]  H. Asao,et al.  Impairment of ligand binding and growth signaling of mutant IL-2 receptor gamma-chains in patients with X-linked severe combined immunodeficiency. , 1994, Journal of immunology.

[6]  I. Campbell,et al.  Building proteins with fibronectin type III modules. , 1994, Structure.

[7]  K. Arai,et al.  Sharing of the interleukin-2 (IL-2) receptor gamma chain between receptors for IL-2 and IL-4. , 1993, Science.

[8]  M. Ultsch,et al.  The X-ray structure of a growth hormone–prolactin receptor complex , 1994, Nature.

[9]  T. Holak,et al.  Structure and dynamics of the human granulocyte colony-stimulating factor determined by NMR spectroscopy. Loop mobility in a four-helix-bundle protein. , 1994, Biochemistry.

[10]  S E Ealick,et al.  Three-dimensional structure of recombinant human interferon-gamma. , 1991, Science.

[11]  A Wlodawer,et al.  Structural comparisons among the short-chain helical cytokines. , 1994, Structure.

[12]  I. Campbell,et al.  Secondary structure and backbone dynamics of human granulocyte colony-stimulating factor in solution. , 1994, Biochemistry.

[13]  A. Miyajima,et al.  Identification of three adjacent amino acids of interleukin‐2 receptor beta chain which control the affinity and the specificity of the interaction with interleukin‐2. , 1992, The EMBO journal.

[14]  N. Nicola,et al.  Histidine-367 of the human common beta chain of the receptor is critical for high-affinity binding of human granulocyte-macrophage colony-stimulating factor. , 1994, Proceedings of the National Academy of Sciences of the United States of America.

[15]  K. Yasukawa,et al.  Structure‐function analysis of human IL‐6 receptor: dissociation of amino acid residues required for IL‐6‐binding and for IL‐6 signal transduction through gp130. , 1993, The EMBO journal.

[16]  G. Yancopoulos,et al.  The alphas, betas, and kinases of cytokine receptor complexes , 1993, Cell.

[17]  J. Wells Structural and functional basis for hormone binding and receptor oligomerization. , 1994, Current opinion in cell biology.

[18]  S. Rose-John,et al.  Identification of two novel regions of human IL-6 responsible for receptor binding and signal transduction. , 1994, Journal of immunology.

[19]  S. Dower,et al.  Oncostatin M and leukemia inhibitory factor trigger overlapping and different signals through partially shared receptor complexes. , 1994, The Journal of biological chemistry.

[20]  N. Sato,et al.  Multimeric cytokine receptors: common versus specific functions. , 1994, Current opinion in cell biology.

[21]  Y. Mitsui,et al.  Three‐dimensional crystal structure of recombinant murine interferon‐beta. , 1992, The EMBO journal.

[22]  J. Wells,et al.  Comparison of a structural and a functional epitope. , 1993, Journal of molecular biology.

[23]  D. Stuart,et al.  The crystal structure and biological function of leukemia inhibitory factor: Implications for receptor binding , 1994, Cell.

[24]  J. Bazan Emerging families of cytokines and receptors , 1993, Current Biology.

[25]  S. Ziegler,et al.  Interleukin-2 receptor gamma chain: a functional component of the interleukin-7 receptor. , 1993, Science.

[26]  J. Schullek,et al.  Mutational mapping of functional residues in tissue factor: identification of factor VII recognition determinants in both structural modules of the predicted cytokine receptor homology domain. , 1994, Biochemistry.

[27]  S. Sprang,et al.  Cytokine structural taxonomy and mechanisms of receptor engagement , 1993 .

[28]  M. F. Shannon,et al.  Two contiguous residues in human interleukin-3, Asp21 and Glu22, selectively interact with the alpha- and beta-chains of its receptor and participate in function. , 1994, The Journal of biological chemistry.

[29]  M. Lambert,et al.  A novel dimer configuration revealed by the crystal structure at 2.4 Å resolution of human interleukin-5 , 1993, Nature.

[30]  J. Pandit,et al.  Three-dimensional structure of dimeric human recombinant macrophage colony-stimulating factor. , 1992, Science.

[31]  K. Flaherty,et al.  Definition and spatial location of mouse interleukin‐2 residues that interact with its heterotrimeric receptor. , 1993, The EMBO journal.

[32]  W. Sebald,et al.  Two distinct functional sites of human interleukin 4 are identified by variants impaired in either receptor binding or receptor activation. , 1993, The EMBO journal.

[33]  M. F. Shannon,et al.  Specific human granulocyte-macrophage colony-stimulating factor antagonists. , 1994, Proceedings of the National Academy of Sciences of the United States of America.

[34]  M. Ultsch,et al.  The crystal structure of affinity-matured human growth hormone at 2 A resolution. , 1994, Journal of molecular biology.

[35]  M. Ultsch,et al.  Comparison of the intermediate complexes of human growth hormone bound to the human growth hormone and prolactin receptors , 1994, Protein science : a publication of the Protein Society.

[36]  C. Cochrane,et al.  Identification of a regulatory domain of the interleukin-6 receptor. , 1994, The Journal of biological chemistry.

[37]  V. Fung,et al.  Cloning of a T cell growth factor that interacts with the beta chain of the interleukin-2 receptor. , 1994, Science.

[38]  D. Eisenberg,et al.  Crystal structure of canine and bovine granulocyte-colony stimulating factor (G-CSF). , 1993, Journal of molecular biology.

[39]  M. Ultsch,et al.  Structure of the extracellular domain of human tissue factor: location of the factor VIIa binding site. , 1994, Biochemistry.

[40]  H. Lodish,et al.  Activation and inhibition of erythropoietin receptor function: role of receptor dimerization , 1994, Molecular and cellular biology.

[41]  I. Campbell,et al.  Structure-function studies of CD2 by n.m.r. and mutagenesis. , 1993, Biochemical Society transactions.

[42]  D. Stuart,et al.  Crystal structure of the extracellular region of human tissue factor , 1994, Nature.

[43]  M. Preece,et al.  A single amino acid substitution in the exoplasmic domain of the human growth hormone (GH) receptor confers familial GH resistance (Laron syndrome) with positive GH‐binding activity by abolishing receptor homodimerization. , 1994, The EMBO journal.

[44]  H Oschkinat,et al.  Receptor binding properties of four‐helix‐bundle growth factors deduced from electrostatic analysis , 1994, Protein science : a publication of the Protein Society.

[45]  P. Heinrich,et al.  Development of a human interleukin-6 receptor antagonist. , 1994, The Journal of biological chemistry.

[46]  D Eisenberg,et al.  The structure of granulocyte-colony-stimulating factor and its relationship to other growth factors. , 1993, Proceedings of the National Academy of Sciences of the United States of America.

[47]  M. Ultsch,et al.  Human growth hormone and extracellular domain of its receptor: crystal structure of the complex. , 1992, Science.